Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

about

Trajectories of plasma IGF-1, IGFBP-3, and their ratio in the Mayo Clinic Study of Aging.Early Life Stress and Epigenetics in Late-onset Alzheimer's Dementia: A Systematic Review

P2860

Q51767673-AB6332DA-10EA-4788-928B-84760A36D627 Q58549216-7EA42698-1409-44CE-95EF-D2ADDF61B94D

P2860

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q36030348

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

@ast

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

@en

type

Item

label

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

@ast

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

@en

prefLabel

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

@ast

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

@en

P1476

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

@en

P2093

Andrew Barszczyk

http://www.w3.org/2001/XMLSchema#string

Julia Forstenpointner

http://www.w3.org/2001/XMLSchema#string

Philip P Ostrowski

http://www.w3.org/2001/XMLSchema#string

Wenhua Zheng

http://www.w3.org/2001/XMLSchema#string

Zhong-Ping Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

Insulin and insulin-like growth factor signalling in neoplasia

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Neurodevelopmental effects of insulin-like growth factor signaling.

Reduced IGF-1 signaling delays age-associated proteotoxicity in mice

Protein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model.

Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence

Insulin-like growth factor-1 selectively increases glucose utilization in brains of aged animals.

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.

Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice.

P304

e0155733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1371/JOURNAL.PONE.0155733

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27227831

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4881955

http://www.w3.org/2001/XMLSchema#string

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

about

P2860

P2860

Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932